// Archives

Fall-Winter 2010

This category contains 6 posts

Please see our latest edition of our newsletter!


Mouse Study Shows Effect of Blood Pressure Drug on Alzheimer’s Disease

From 11/15/2010 NIA News Release, with Response by Sam Gandy, M.D. A drug used decades ago to treat high blood pressure has been shown to improve learning and memory in mouse models of Alzheimer’s disease, according to a new study by researchers at the National Institute on Aging (NIA), part of the National Institutes of […]

Ask the Expert: Do any of the prevention strategies for Alzheimer’s have any merit? I heard that there was a recent NIH panel that said that none of them were useful!

Ask the expert: Judith Neugroschl, M.D. The NIH recently sponsored a panel made up of 15 specialists in a variety of fields of medicine and public health, along with 20 expert presenters, in order to assess the current research on Alzheimer’s disease prevention. They came up with a consensus statement with a couple of major […]

Gene Linked to Increased Risk of Alzheimer’s Disease

Adapted by Steven Hoover from the 9/24/2010 EmaxHealth posting by Deborah Mitchell Researchers are one step closer to discovering the genetic precursors to lateonset Alzheimer’s disease, the most common type of the disease. Investigators from four institutions, including Dr. Joseph Buxbaum of Mount Sinai Medical Center, collaborated to discover the role of variations in a […]

New Ways to Diagnose Alzheimer’s Disease

Over the past 25 years there have been few changes in the diagnosis of Alzheimer disease (AD) even though our knowledge of the disease and its progression has grown. For example, the current criteria have age cutoffs (between 40 and 90 years of age), but we know now that many people living into their 90’s […]

Gene Associated with Type 2 Diabetes Is Low in People with Alzheimer’s Disease

From October 12, 2010 MSSM Press Release Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer’s disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of […]